SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for PRCT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 252.06M
March 31, 2026 238.70M
December 31, 2025 228.81M
September 30, 2025 218.83M
June 30, 2025 202.51M
March 31, 2025 187.01M
December 31, 2024 171.42M
September 30, 2024 159.42M
June 30, 2024 149.61M
March 31, 2024 141.24M
December 31, 2023 131.77M
September 30, 2023 121.49M
Date Value
June 30, 2023 113.36M
March 31, 2023 100.57M
December 31, 2022 88.83M
September 30, 2022 79.06M
June 30, 2022 66.43M
March 31, 2022 59.07M
December 31, 2021 51.04M
September 30, 2021 34.77M
June 30, 2021 29.70M
March 31, 2021 17.40M
December 31, 2020 7.054M
September 30, 2020 7.054M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Insulet Corp. 1.309B
Globus Medical, Inc. 1.217B
Abbott Laboratories 13.94B
Alphatec Holdings, Inc. 524.06M
Artivion, Inc. 254.77M